Market Overview
Between 2026 and 2031, the Netherlands pet healthcare market is projected to post incremental gains of USD 24.3 million, advancing at a CAGR close to 3.8%. Growth will be supported by rising pet ownership and the continued humanisation of pets, as Dutch owners increasingly view animal health as part of everyday household responsibility. This is making preventive care more important, with healthcare products benefiting from demand that is more durable than discretionary pet purchases.
Parasite prevention will remain a stable foundation for the category. Regular flea and worm treatments are already well understood by pet owners and should continue to generate recurring demand. As owners become more proactive about pets’ physical wellbeing, these routine treatments are likely to be complemented by broader preventive solutions that help reduce future health risks and support longer, healthier lives.
Dietary supplements are set to become the main area of innovation. With pets living longer, demand is expected to rise for products targeting senior dogs and cats, including joint health, mobility, digestion, weight management, dental health, anxiety, and skin and coat condition. Combination formulas using ingredients such as glucosamine, chondroitin, MSM and collagen are likely to gain visibility as owners seek products that improve comfort and quality of life in ageing pets.
Convenient formats will be central to wider adoption. Chewable treats, oils and drops can make supplements easier to administer, helping owners incorporate preventive care into daily routines. As e-commerce expands, subscription models may further support repeat purchases of supplements and other regularly used healthcare products. The strongest performers will be brands that combine clear health benefits, ease of use and credible positioning in a market where owners are increasingly informed but still attentive to value.
This report delivers a comprehensive analysis and forward-looking perspective on the Netherlands pet healthcare market, covering historical data and market projections for the period from 2021 to 2031. By examining market size, growth rates, and segmented insights, the report highlights the dynamic shifts and emerging trends shaping the industry. It provides a granular breakdown across key dimensions, including product type and distribution channel, offering stakeholders a detailed roadmap for strategic decision-making.
What’s Inside the Report
This report provides a detailed assessment of the Netherlands pet healthcare market, including historical data and forward-looking projections through 2031. It breaks down the industry by product type and distribution channel, with compound annual growth rates (CAGRs) for both past performance and forecast periods. By analyzing growth trajectories, the study pinpoints high-opportunity segments to inform strategic investments.
Also included in the report is an analysis of the market’s underlying trends and drivers. Informed by executive-level interviews and verified macro-level data, this section explores the fundamental shifts influencing demand and competition. It outlines how changes in innovation cycles, and consumer expectations have affected recent developments, while pointing to segments with the greatest forward momentum and associated risks.
Furthermore, the report delivers a rigorous competitive assessment, tracking market share movements and brand performance among industry participants from 2021 onward. It highlights evolving competitive dynamics, consolidation trends, and granular share shifts, empowering stakeholders to benchmark performance and refine differentiation strategies. These evidence-based insights support targeted investment prioritization and long-term strategic planning.
Market Segmentation
The Netherlands pet healthcare market is structured as follows:
Product type – e.g., flea and tick prevention products, pet vitamins and supplements, pet wormers, others
Distribution channel – e.g., discounters, e-commerce, health stores, hypermarkets, supermarkets, others
Macroeconomic & Demographic Indicators
In addition to core market data, the report incorporates key socio-economic indicators that provide essential context for interpreting market dynamics. These include population trends, the Consumer Price Index (CPI), Gross Domestic Product (GDP), per capita consumption (expressed in USD), and consumer spending as a percentage of GDP. Together, these metrics offer a macroeconomic backdrop that enhances the strategic relevance of the market size figures, helping stakeholders better assess demand potential and long-term growth opportunities.
Competitive Landscape: Market Share Analysis
Market share insights presented in this report illustrate the evolving competitive landscape of the pet healthcare sector in Netherlands, with data on top-performing brands and consolidation trends. Key market participants include: Beaphar B.V., Boehringer Ingelheim Auslandsbeteiligungs GmbH, Elanco Animal Health Incorporated, Emax Nederland B.V., Nederma B.V., Pasco International, Spijker Holding, Versele-Laga NV, Woef Hap Nederland BV, etc.
This section helps stakeholders evaluate market concentration, identify partnership opportunities, and track shifts in leadership.
Why Choose This Report?
Designed as a data-rich strategic snapshot, the report delivers timely and reliable intelligence to support decisions across market entry, investment evaluation, supply chain planning, and competitive benchmarking. Whether you’re an investor, manufacturer, distributor, or consultant, this report delivers actionable value.
Request a redacted sample to preview the data structure and presentation quality before purchase.
Deliverables Include
Professionally structured PDF report
Full EXCEL databook with year-by-year figures and multi-dimensional segmentation from 2021 to 2031
Table of Contents
TABLE OF CONTENTS
Market Segmentation
Market Overview
Netherlands Pet Healthcare Market – Product Type Analysis
Netherlands Pet Healthcare Market – Distribution Channel Analysis
Company/Brand Shares Analysis
Beaphar B.V.
Boehringer Ingelheim Auslandsbeteiligungs GmbH
Elanco Animal Health Incorporated
Emax Nederland B.V.
Nederma B.V.
…
Macroeconomic Data and Forecast
Research Methodology
Disclaimer
FIGURES AND TABLES
Table Netherlands Pet Healthcare Market 2021-2031
Chart Netherlands Pet Healthcare Market, Net Growth, 2021-2031
Chart Netherlands Pet Healthcare Market, Growth Rates, 2021-2031
Table Netherlands Pet Healthcare Market by Product Type, 2021-2031
Chart Netherlands Pet Healthcare Market by Product Type, CAGR Historic and Forecast, 2021-2031
Chart Netherlands Pet Healthcare Market by Product Type, 2021-2031
Table Netherlands Pet Healthcare Market by Distribution Channel, 2021-2031
Chart Netherlands Pet Healthcare Market by Distribution Channel, CAGR Historic and Forecast, 2021-2031
Chart Netherlands Pet Healthcare Market by Distribution Channel, 2021-2031
Table Netherlands Pet Healthcare Market Share (%), by Companies, 2021-2025
Chart Netherlands Pet Healthcare Market, by Companies, 2025
Table Netherlands Pet Healthcare Market Share (%), by Brands, 2021-2025
Chart Netherlands Pet Healthcare Market, by Brands, 2025
Table Netherlands – Population (Millions) and Forecast
Table Netherlands – Consumer Price Index (CPI) and Forecast
Table Netherlands – Gross Domestic Product and Forecast
Table Netherlands Pet Healthcare Market: Spend as a Proportion of GDP (%)
Table Netherlands Pet Healthcare Market: Consumption per Capita (Population)
Companies Mentioned
The companies profiled in this Netherlands Pet Healthcare market report include:
Beaphar B.V.
Boehringer Ingelheim Auslandsbeteiligungs GmbH
Elanco Animal Health Incorporated
Emax Nederland B.V.
Nederma B.V.
Pasco International
Spijker Holding
Versele-Laga NV
Woef Hap Nederland BV
